Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Study: Intervention raises costs for diabetes
Medical Economics, 10/21/09
Lewis M – Medical interventions for patients with type 2 diabetes won't reduce health costs over the long term, according to a recently published study, but that doesn't mean they don't offer benefits.
Related Articles
Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09
Relevance Score: 67%
Diverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09
Relevance Score: 65%
Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09
Relevance Score: 65%
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09
Relevance Score: 64%
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 48%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
"Better Ways to Pay for Health Care", Recommended by National Health Care Quality Coalition
AMN Healthcare, 11/25/09
Stimulating EMR adoption
American Medical News , 11/25/09
Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


